Predrag Kalaba

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Risk

Mesenchymal Stem Cells

Positron Emission Tomography

Energy Transfer

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Eduardo Rene Perez Gonzalez, Bernhard Reck, Predrag Kalaba, Thierry Langer, Johann Leban, Gert Lubec
Process Development and Scale-Up of a Novel Atypical DAT Inhibitor ( S )-CE-123. ACS omega 9 (11) (2024)
Predrag Kalaba, Cristina Sanchez de la Rosa, Andreas Möller, Paul F Alewood, Markus Muttenthaler
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers. Journal of medicinal chemistry 67 (3) (2024)
Eduardo Rene Perez Gonzalez, Bernhard Reck, Predrag Kalaba, Thierry Langer, Johann Leban, Gert Lubec
Process Development and Scale-Up of a Novel Atypical DAT Inhibitor ( S )-CE-123. ACS omega 9 (11) (2024)
Predrag Kalaba, Cristina Sanchez de la Rosa, Andreas Möller, Paul F Alewood, Markus Muttenthaler
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers. Journal of medicinal chemistry 67 (3) (2024)
Predrag Kalaba, Cristina Sanchez de la Rosa, Andreas Möller, Paul F Alewood, Markus Muttenthaler
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers. Journal of medicinal chemistry (2024)
Predrag Kalaba, Cristina Sanchez de la Rosa, Andreas Möller, Paul F Alewood, Markus Muttenthaler
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers. Journal of medicinal chemistry 67 (3) (2024)
Predrag Kalaba, Cristina Sanchez de la Rosa, Andreas Möller, Paul F Alewood, Markus Muttenthaler
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers. Journal of medicinal chemistry 67 (3) (2024)